TD Cowen Maintains Buy on CME Group, Raises Price Target to $300

TD Cowen analyst Bill Katz has maintained a 'Buy' rating on CME Group (NASDAQ: CME) and increased the price target from $292 to $300. This adjustment reflects a positive outlook for the company's stock performance.